GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
69,800
+2,500 (3.71%)
Jun 13, 2025, 3:30 PM KST
538.03%
Market Cap 2.87T
Revenue (ttm) 60.33B
Net Income (ttm) -61.59B
Shares Out 41.09M
EPS (ttm) -1,551.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 427,531
Average Volume 320,539
Open 69,500
Previous Close 67,300
Day's Range 64,100 - 69,800
52-Week Range 9,060 - 69,800
Beta 1.02
RSI 88.69
Earnings Date Aug 14, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1998
Employees 192
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial Statements

News

There is no news available yet.